UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fat mass: a novel digital biomarker for remote monitoring that may indicate risk for malnutrition and new complications in decompensated cirrhosis

BMC medical informatics and decision making, 2023-09, Vol.23 (1), p.1-7, Article 180

2023

Volltextzugriff (PDF)

Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study

Alimentary pharmacology & therapeutics, 2024-08, Vol.60 (7), p.907-920

2024

Volltextzugriff (PDF)

P11 CL-ART: A Novel Smartphone Application That Can Help Predict Future Hospitalisation Secondary to Cirrhosis Acute Decompensation

The American journal of gastroenterology, 2023-09, Vol.118 (9S), p.S9-S9

2023

Volltextzugriff (PDF)

Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats

Scientific reports, 2017-12, Vol.7 (1), p.17900-10, Article 17900

2017

Volltextzugriff (PDF)

Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis

Gut, 2003-08, Vol.52 (8), p.1182-1187

2003

Volltextzugriff (PDF)

'Out-patient' albumin dialysis for cholestatic patients with intractable pruritus

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (6), p.696-704

2012

Volltextzugriff (PDF)

Transgressive Fiction: The New Satiric Tradition

Mookerjee, R

1, 2013

Volltextzugriff (PDF)

P0151 : Covert hepatic encephalopathy comprises two clinically and pathophysiologically distinct syndromes: A prospective longitudinal study

Journal of hepatology, 2015-04, Vol.62, p.S358-S358

2015

Volltextzugriff (PDF)

Soluble CD163, a Marker of Macrophage Activation, is Increased in Early Allograft Dysfunction after Liver Transplantation

Journal of hepatology, 2016, Vol.64 (2), p.S544-S544

2016

Volltextzugriff (PDF)

Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis

American journal of physiology: Gastrointestinal and liver physiology, 2009-01, Vol.296 (1), p.G15-G22

2009

Volltextzugriff (PDF)

O091 : Oral therapy with non-absorbable carbons of controlled porosity (YAQ-001) selectively modulates stool microbiome and its function and this is associated with restoration of immune function and inflammasome activation

Journal of hepatology, 2015-04, Vol.62, p.S240-S240

2015

Volltextzugriff (PDF)

O70 LIFETOUCH: A NOVEL REMOTE MONITORING DEVICE TO IDENTIFY PATIENTS WITH ADVANCED CIRRHOSIS MOST AT RISK OF DECOMPENSATION – A PROOF OF CONCEPT STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S29-S29

2014

Volltextzugriff (PDF)

Cellular Neutrophil Dysfunction is a Feature of Early Cirrhosis and Associated with an Increased Risk of Decompensation and Bacterial Infection

Journal of hepatology, 2016, Vol.64 (2), p.S513-S513

2016

Volltextzugriff (PDF)

O15 EFFECTS OF THE FXR AGONIST OBETICHOLIC ACID ON HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN ALCOHOLIC CIRRHOSIS: A PROOF OF CONCEPT PHASE 2A STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S7-S8

2014

Volltextzugriff (PDF)

588 ALBUMIN RESTORES RENAL BLOOD FLOW (RBF) AUTOREGULATION IN PATIENTS WITH REFRACTORY ASCITES AND ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) THROUGH STABILIZATION OF ENDOTHELIAL FUNCTION

Journal of hepatology, 2012-04, Vol.56, p.S233-S234

2012

Volltextzugriff (PDF)

P91 EFFECT OF TOLL-LIKE RECEPTOR 7 AND 9 TARGETED THERAPY TO PREVENT THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2014-04, Vol.60 (1), p.S96-S97

2014

Volltextzugriff (PDF)

595 INFLAMMATION UPREGULATES HEPATIC CONNEXIN-43 EXPRESSION IN CIRRHOSIS WHICH DEFINES SUSCEPTIBILITY TO DEVELOPMENT OF ACUTE-ON CHRONIC LIVER FAILURE

Journal of hepatology, 2012-04, Vol.56, p.S236-S236

2012

Volltextzugriff (PDF)

534 MUSCLE GLUTAMINE SYNTHASE REGULATES THE SEVERITY OF HYPERAMMONEMIA, HEPATIC INFLAMMATION, BRAIN SWELLING AND SURVIVAL IN ACETAMINOPHEN HEPATOTOXICITY

Journal of hepatology, 2013-04, Vol.58, p.S218-S219

2013

Volltextzugriff (PDF)

P340 ALBUMIN EXCHANGE AND ENDOTOXIN REMOVAL USING THE NOVEL UCL-LIVER DIALYSIS DEVICE (UCL-LDD) PROLONGS SURVIVAL IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE (ALF)

Journal of hepatology, 2014-04, Vol.60 (1), p.S180-S180

2014

Volltextzugriff (PDF)

243 A REPRODUCIBLE, CLINICALLY-RELEVANT, INTENSIVELY-MANAGED, PIG MODEL OF ACUTE LIVER FAILURE FOR TESTING OF THERAPIES AIMED TO PROLONG SURVIVAL

Journal of hepatology, 2012-04, Vol.56, p.S102-S102

2012

Volltextzugriff (PDF)

1064 TARGETING TLR7 AND 9: A NOVEL STRATEGY FOR TREATMENT OF CHOLANGIOCARCINOMA

Journal of hepatology, 2013-04, Vol.58, p.S436-S437

2013

Volltextzugriff (PDF)

Review article: the Molecular Adsorbents Recirculating System (MARS) in liver failure

Alimentary pharmacology & therapeutics, 2002-12, Vol.16 (s5), p.32-38

2002

Volltextzugriff (PDF)

PMO-127 Biological effects of oral nanoporous carbon in bile duct ligated rats

Gut, 2012-07, Vol.61 (Suppl 2), p.A124-A124

2012

Volltextzugriff (PDF)

PMO-128 Effects of oral nanoporous carbon therapy in leptin null mice as a model of non-alcoholic steatohepatitis

Gut, 2012-07, Vol.61 (Suppl 2), p.A125-A125

2012

Volltextzugriff (PDF)

Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis

Hepatology (Baltimore, Md.), 2015-07, Vol.62 (1), p.243-252

2015

Volltextzugriff (PDF)

1 – 25 von 427

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(373)
Mit Volltextzugriff
(384)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fat mass: a novel digital biomarker for remote monitoring that may indicate risk for malnutrition and new complications in decompensated cirrhosis

Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study

P11 CL-ART: A Novel Smartphone Application That Can Help Predict Future Hospitalisation Secondary to Cirrhosis Acute Decompensation

Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats

Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis

'Out-patient' albumin dialysis for cholestatic patients with intractable pruritus

Transgressive Fiction: The New Satiric Tradition

P0151 : Covert hepatic encephalopathy comprises two clinically and pathophysiologically distinct syndromes: A prospective longitudinal study

Soluble CD163, a Marker of Macrophage Activation, is Increased in Early Allograft Dysfunction after Liver Transplantation

Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis

O091 : Oral therapy with non-absorbable carbons of controlled porosity (YAQ-001) selectively modulates stool microbiome and its function and this is associated with restoration of immune function and inflammasome activation

O70 LIFETOUCH: A NOVEL REMOTE MONITORING DEVICE TO IDENTIFY PATIENTS WITH ADVANCED CIRRHOSIS MOST AT RISK OF DECOMPENSATION – A PROOF OF CONCEPT STUDY

Cellular Neutrophil Dysfunction is a Feature of Early Cirrhosis and Associated with an Increased Risk of Decompensation and Bacterial Infection

O15 EFFECTS OF THE FXR AGONIST OBETICHOLIC ACID ON HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN ALCOHOLIC CIRRHOSIS: A PROOF OF CONCEPT PHASE 2A STUDY

588 ALBUMIN RESTORES RENAL BLOOD FLOW (RBF) AUTOREGULATION IN PATIENTS WITH REFRACTORY ASCITES AND ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) THROUGH STABILIZATION OF ENDOTHELIAL FUNCTION

P91 EFFECT OF TOLL-LIKE RECEPTOR 7 AND 9 TARGETED THERAPY TO PREVENT THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA

595 INFLAMMATION UPREGULATES HEPATIC CONNEXIN-43 EXPRESSION IN CIRRHOSIS WHICH DEFINES SUSCEPTIBILITY TO DEVELOPMENT OF ACUTE-ON CHRONIC LIVER FAILURE

534 MUSCLE GLUTAMINE SYNTHASE REGULATES THE SEVERITY OF HYPERAMMONEMIA, HEPATIC INFLAMMATION, BRAIN SWELLING AND SURVIVAL IN ACETAMINOPHEN HEPATOTOXICITY

P340 ALBUMIN EXCHANGE AND ENDOTOXIN REMOVAL USING THE NOVEL UCL-LIVER DIALYSIS DEVICE (UCL-LDD) PROLONGS SURVIVAL IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE (ALF)

243 A REPRODUCIBLE, CLINICALLY-RELEVANT, INTENSIVELY-MANAGED, PIG MODEL OF ACUTE LIVER FAILURE FOR TESTING OF THERAPIES AIMED TO PROLONG SURVIVAL

1064 TARGETING TLR7 AND 9: A NOVEL STRATEGY FOR TREATMENT OF CHOLANGIOCARCINOMA

Review article: the Molecular Adsorbents Recirculating System (MARS) in liver failure

PMO-127 Biological effects of oral nanoporous carbon in bile duct ligated rats

PMO-128 Effects of oral nanoporous carbon therapy in leptin null mice as a model of non-alcoholic steatohepatitis

Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis

Suchergebnisse filtern